Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran

ConclusionAccording to the results, it is recommended that health policymakers consider the use of valsartan by cardiologists when designing clinical guidelines for the treatment of patients with heart failure.
Source: Health Economics Review - Category: International Medicine & Public Health Source Type: research